Suspected Acute Pulmonary Coccidioidomycosis in Traveler Returning to Switzerland from Peru
Andreas Neumayr
1 , Volker Rickerts
1, Sina Ackermann, Felipe Castelblanco, Esther Kuenzli, Ana Durovic
1, and Carlos Seas
1
Author affiliation: James Cook University, Townsville, Queensland, Australia (A. Neumayr); Swiss Tropical and Public Health Institute, Basel, Switzerland (A. Neumayr, E. Kuenzli, A. Durocic); University of Basel, Basel (A. Neumayr, E. Kuenzli, A. Durocic); Robert Koch Institute, Berlin, Germany (V. Rickerts, S. Ackermann); Institute Art Gender Nature Basel Academy of Art and Design FHNW, Basel (F. Castelblanco); Universidad Peruana Cayetano Heredia, Lima, Peru (C. Seas); Hospital Cayetano Heredia, Lima (C. Seas).
Main Article
Figure 1
Figure 1. Computed tomography scan findings of a patient with a suspected case of coccidioidomycosis contracted in Peru and the changes in findings seen over 12 months while in treatment in Switzerland, 2022 and 2023. Blue arrows highlight the pulmonary consolidation and regression over time. White arrows highlight the enlarged infracarinal lymphnodes and their regression and normalization over time.
Main Article
Page created: October 08, 2024
Page updated: October 23, 2024
Page reviewed: October 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.